Future US policy debates regarding the connection between prescription drug rebates and insurance costs will be informed by a transparency requirement tucked into the $900bn economic stimulus and US government funding bill signed into law on 28 December.
Known as the Consolidated Appropriations Act, the law directs government sponsored and commercial health plans to report manufacturer rebates...







